Integrated bioassays and metabolomics identify Cleome noeana as a promising antibacterial candidate
Frontiers in Microbiology · 27.03.2026 · 17
DOI: 10.3389/fmicb.2026.1777863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 27.03.2026. Verfasst von Ali El-Keblawy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biology, College of Sciences, University of Sharjah, Sharjah, United Arab Emirates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial resistance has intensified the search for novel antibacterial agents from underexplored desert flora. This study compared three arid-region Cleome species to identify the most active candidate against Escherichia coli, Salmonella enterica , and Staphylococcus aureus , and to relate its antibacterial performance to metabolite composition and compatibility with bacteriophage treatment. An in vitro workflow combined crude-extract antibacterial screening, agar diffusion assays, time-kill kinetics, and untargeted GC–MS metabolomics coupled with multivariate analysis. Among the tested species, Cleome noeana exhibited the broadest and strongest antibacterial activity, with minimum inhibitory concentrations of 6.25–25 mg/mL and MBC/MIC ratios ≤ 4. Inhibition zone diameters were inversely correlated with MIC values. Time-kill assays demonstrated that C. noeana extracts reduced viable bacterial counts more rapidly than bacteriophages or antibiotics alone, while extract–phage combinations achieved >99% inhibition within 4 h, indicating phage compatibility with accelerated killing rather than true synergism. Untargeted metabolomic profiling tentatively associated antibacterial activity with phenolic acids, terpenoids, and long-chain fatty acids, including caffeic acid, α-terpineol, and myristic acid. Overall, Cleome noeana emerges as a promising antibacterial species from desert ecosystems and a plant extract compatible with bacteriophage-based approaches, supporting further targeted isolation and in vivo evaluation of its bioactive constituents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Applied Biology, College of Sciences, University of Sharjah, Sharjah, United Arab Emirates.
- Faculty of Pharmacy, Al Salam University, Tanta, Egypt.
- Faculty of Science, Botany and Microbiology Department, Menoufia University, Shebeen El-Kom, Egypt.
- Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
- Department of Clinical Nutrition and Dietetics, College of Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
- Department of Nutrition and Food Technology, Faculty of Agriculture, Jordan University of Science and Technology, Irbid, Jordan.
Zitieren
APA
El-Keblawy, A., Sallam, O., Osaili, T. M., Lamghari, F., Al Moalla, A., Sheteiwy, M., Alarjani, K. M., Manikandan, S. K., & Elnaggar, A. (2026). Integrated bioassays and metabolomics identify Cleome noeana as a promising antibacterial candidate. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1777863
Vancouver
El-Keblawy A, Sallam O, Osaili TM, Lamghari F, Al Moalla A, Sheteiwy M, et al. Integrated bioassays and metabolomics identify Cleome noeana as a promising antibacterial candidate. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1777863
BibTeX
@article{ElKeblawy2026,
author = {El-Keblawy, Ali and Sallam, Ohood and Osaili, Tareq M and Lamghari, Fouad and Al Moalla, Aseela and Sheteiwy, Mohamed and Alarjani, Khaloud Mohammed and Manikandan, Soumya Koippully and Elnaggar, Attiat},
title = {Integrated bioassays and metabolomics identify Cleome noeana as a promising antibacterial candidate},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1777863}
}
EUVIMED